loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about 1-cyclopropyl-8-(difluoromethoxy)-7-(1-methyl-2,3-dihydro-1H-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid methanesulfonate monohydrate, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    1-cyclopropyl-8-(difluoromethoxy)-7-(1-methyl-2,3-dihydro-1H-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid methanesulfonate monohydrate

    APIs // Active Pharmaceutical Ingredients

    PRICE INFORMATION

    MARKET PLACE

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Temad- We think of world-class quality.

    2D Structure
    1. Also known as: Garenoxacin mesylate, 223652-82-2, Bms 284756, Bms-284756, 437zku48cf, Garenoxacin methanesulfonate
    Molecular Formula
    C24H24F2N2O7S
    Molecular Weight
    522.5  g/mol
    InChI Key
    UPHLDCUEQOTSAD-RFVHGSKJSA-N
    FDA UNII
    437ZKU48CF
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxoquinoline-3-carboxylic acid;methanesulfonic acid
    2.1.2 InChI
    InChI=1S/C23H20F2N2O4.CH4O3S/c1-11-15-5-2-12(8-13(15)9-26-11)16-6-7-17-19(21(16)31-23(24)25)27(14-3-4-14)10-18(20(17)28)22(29)30;1-5(2,3)4/h2,5-8,10-11,14,23,26H,3-4,9H2,1H3,(H,29,30);1H3,(H,2,3,4)/t11-;/m1./s1
    2.1.3 InChI Key
    UPHLDCUEQOTSAD-RFVHGSKJSA-N
    2.1.4 Canonical SMILES
    CC1C2=C(CN1)C=C(C=C2)C3=C(C4=C(C=C3)C(=O)C(=CN4C5CC5)C(=O)O)OC(F)F.CS(=O)(=O)O
    2.1.5 Isomeric SMILES
    C[C@@H]1C2=C(CN1)C=C(C=C2)C3=C(C4=C(C=C3)C(=O)C(=CN4C5CC5)C(=O)O)OC(F)F.CS(=O)(=O)O
    2.2 Other Identifiers
    2.2.1 UNII
    437ZKU48CF
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Bms 284756

    2. Bms-284756

    3. Bms284756

    4. Garenoxacin

    2.3.2 Depositor-Supplied Synonyms

    1. Garenoxacin Mesylate

    2. 223652-82-2

    3. Bms 284756

    4. Bms-284756

    5. 437zku48cf

    6. Garenoxacin Methanesulfonate

    7. Garenoxacin Mesylate Anhydrous

    8. Unii-437zku48cf

    9. Bms 284756-01

    10. Schembl1649428

    11. Dtxsid4058732

    12. Bcp17552

    13. T 3811me

    14. Garenoxacin Mesilate [mart.]

    15. Garenoxacin Mesilate [who-dd]

    16. Garenoxacin Mesylate / Methanesulfonate

    17. Garenoxacin Methanesulfonate [mi]

    18. (+)-garenoxacin Mesylate Anhydrous

    19. 652g902

    20. Q27258626

    21. (r)-1-cyclo-propyl-8-difluoromethoxy-7-(1-methyl-2,3-dihydro-1h-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic Acid Methanesulfonate

    22. (r)-1-cyclopropyl-8-(difluoromethoxy)-7-(1-methyl-2,3-dihydro-1h-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic Acid Methanesulfonate

    23. (r)-1-cyclopropyl-8-difluoromethoxy-7-(1-methyl-2,3-dihydro-1h-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic Acid Methanesulfonate

    24. 1-cyclopropyl-8-(difluoromethoxy)-7-((1r)-1-methyl-2,3-dihydro-1h-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic Acid Mesylate

    25. 1-cyclopropyl-8-(difluoromethoxy)-7-(1-methyl-2,3-dihydro-1h-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic Acid Methanesulfonate Monohydrate

    26. 1-cyclopropyl-8-(difluoromethoxy)-7-[(1r)-1-methyl-2,3-dihydro-1h-isoindol-5-yl]-4-oxoquinoline-3-carboxylic Acid;methanesulfonic Acid

    27. 3-quinolinecarboxylic Acid, 1-cyclopropyl-8-(difluoromethoxy)-7-((1r)-2,3-dihydro-1-methyl-1h-isoindol-5-yl)-1,4-dihydro-4-oxo-, Monomethanesulfonate

    28. 3-quinolinecarboxylic Acid, 1-cyclopropyl-8-(difluoromethoxy)-7-((1r)-2,3-dihydro-1-methyl-1h-isoindol-5-yl)-1,4-dihydro-4-oxo-, Methanesulfonate (1:1)

    2.4 Create Date
    2005-08-08
    3 Chemical and Physical Properties
    Molecular Weight 522.5 g/mol
    Molecular Formula C24H24F2N2O7S
    Hydrogen Bond Donor Count3
    Hydrogen Bond Acceptor Count11
    Rotatable Bond Count5
    Exact Mass522.12722861 g/mol
    Monoisotopic Mass522.12722861 g/mol
    Topological Polar Surface Area142 Ų
    Heavy Atom Count36
    Formal Charge0
    Complexity863
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Topoisomerase II Inhibitors

    Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)

    Anti-Bacterial Agents

    Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)

    Post Enquiry
    POST ENQUIRY